Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. (ALNY) — Form 4: Insider transaction

4ALNYFiled Sep 22, 2026, 4:07 PM ET· Period Sep 19, 2026

About this filing

Alnylam Pharmaceuticals, Inc. (ALNY) filed Form 4 (insider transaction) with the SEC on Sep 22, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov

Key facts

Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.

More ALNY filings

SC 13G
Ownership over 5% (passive)
Filed Oct 30, 2026
10-Q
Quarterly report
Filed Oct 29, 2026
8-K
Current report
Filed Oct 29, 2026
4
Insider transaction
Filed Oct 6, 2026
144
Proposed sale of shares
Filed Oct 2, 2026
10-Q
Quarterly report
Filed Jul 30, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.